Yamashita S - Search Results

1

Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.

Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, Fawcett H, Wing JF, Lewin SO, Carr L, Li TS, Yoshiura K, Utani A, Hirano A, Yamashita S, Greenblatt D, Nardo T, Stefanini M, McGibbon D, Sarkany R, Fassihi H, Takahashi Y, Nagayama Y, Mitsutake N, Lehmann AR, Ogi T. Kashiyama K, et al. Among authors: yamashita s. Am J Hum Genet. 2013 May 2;92(5):807-19. doi: 10.1016/j.ajhg.2013.04.007. Epub 2013 Apr 25. Am J Hum Genet. 2013. PMID: 23623389 Free PMC article.

2

Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.

Luo W, Matsuo K, Nagayama Y, Urano T, Furukawa K, Takeshita A, Nakayama T, Yokoyama N, Yamashita S, Izumi M, et al. Luo W, et al. Among authors: yamashita s. Thyroid. 1993 Summer;3(2):105-9. doi: 10.1089/thy.1993.3.105. Thyroid. 1993. PMID: 8396479

3

Distinctive gene expression of receptor-type tyrosine kinase families during rat hepatocarcinogenesis.

Kuroda H, Ohtsuru A, Futakuchi M, Kawashita Y, Nagayama Y, Fukuda E, Namba H, Shirai T, Kanematsu T, Yamashita S. Kuroda H, et al. Among authors: yamashita s. Int J Mol Med. 2002 May;9(5):473-80. Int J Mol Med. 2002. PMID: 11956651

4

Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.

Ishigaki K, Namba H, Nakashima M, Nakayama T, Mitsutake N, Hayashi T, Maeda S, Ichinose M, Kanematsu T, Yamashita S. Ishigaki K, et al. Among authors: yamashita s. J Clin Endocrinol Metab. 2002 Jul;87(7):3433-40. doi: 10.1210/jcem.87.7.8648. J Clin Endocrinol Metab. 2002. PMID: 12107263

5

The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells.

Podtcheko A, Ohtsuru A, Tsuda S, Namba H, Saenko V, Nakashima M, Mitsutake N, Kanda S, Kurebayashi J, Yamashita S. Podtcheko A, et al. Among authors: yamashita s. J Clin Endocrinol Metab. 2003 Apr;88(4):1889-96. doi: 10.1210/jc.2002-021230. J Clin Endocrinol Metab. 2003. PMID: 12679488

6

Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.

Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, Akiyama-Uchida Y, Saenko V, Fujii T, Yamashita S. Daian T, et al. Among authors: yamashita s. J Invest Dermatol. 2003 Jun;120(6):956-62. doi: 10.1046/j.1523-1747.2003.12143.x. J Invest Dermatol. 2003. PMID: 12787120 Free article.

7

Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest.

Bulgin D, Podtcheko A, Takakura S, Mitsutake N, Namba H, Saenko V, Ohtsuru A, Rogounovitch T, Palona I, Yamashita S. Bulgin D, et al. Among authors: yamashita s. Thyroid. 2006 Mar;16(3):217-24. doi: 10.1089/thy.2006.16.217. Thyroid. 2006. PMID: 16571083

8

Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation.

Kumagai A, Namba H, Mitsutake N, Saenko VA, Ohtsuru A, Ito M, Noh JY, Sugino K, Ito K, Yamashita S. Kumagai A, et al. Among authors: yamashita s. Oncol Rep. 2006 Jul;16(1):123-6. Oncol Rep. 2006. PMID: 16786134

9

BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation.

Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I, Ohtsuru A, Saenko V, Nagayama Y, Umezawa K, Yamashita S. Palona I, et al. Among authors: yamashita s. Endocrinology. 2006 Dec;147(12):5699-707. doi: 10.1210/en.2006-0400. Epub 2006 Sep 7. Endocrinology. 2006. PMID: 16959844

10

Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.

Abrosimov A, Saenko V, Rogounovitch T, Namba H, Lushnikov E, Mitsutake N, Yamashita S. Abrosimov A, et al. Among authors: yamashita s. Int J Cancer. 2007 Jan 1;120(1):196-200. doi: 10.1002/ijc.22290. Int J Cancer. 2007. PMID: 17044028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,477 results

Search Page

Filters